Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Decrease in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 3,500 shares, a drop of 73.5% from the December 15th total of 13,200 shares. Based on an average daily volume of 33,700 shares, the short-interest ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Performance

RVPHW traded down $0.09 during trading on Tuesday, hitting $0.24. The stock had a trading volume of 65,170 shares, compared to its average volume of 54,309. Reviva Pharmaceuticals has a 12 month low of $0.07 and a 12 month high of $1.20. The company has a 50 day simple moving average of $0.21 and a 200-day simple moving average of $0.17.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.